Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.

Lesage S, Janin S, Lohmann E, Leutenegger AL, Leclere L, Viallet F, Pollak P, Durif F, Thobois S, Layet V, Vidailhet M, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group, Bonnet AM, Borg M, Broussolle E, Damier P, Destée A, Martinez M, Penet C, Rasco O, Tison F, Tranchan C, Vérin M.

Arch Neurol. 2007 Mar;64(3):425-30.

PMID:
17353388
2.

The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

Thaler A, Ash E, Gan-Or Z, Orr-Urtreger A, Giladi N.

J Neural Transm (Vienna). 2009 Nov;116(11):1473-82. doi: 10.1007/s00702-009-0303-0. Review.

PMID:
19756366
3.

[Clinical molecular genetics for PARK8 (LRRK2)].

Tomiyama H, Hatano T, Hattori N.

Brain Nerve. 2007 Aug;59(8):839-50. Review. Japanese.

PMID:
17713120
4.

Clinical features of LRRK2 parkinsonism.

Haugarvoll K, Wszolek ZK.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S205-8. doi: 10.1016/S1353-8020(09)70815-6. Review.

PMID:
20082991
6.

LRRK2 G2019S in the North African population: a review.

Benamer HT, de Silva R.

Eur Neurol. 2010;63(6):321-5. doi: 10.1159/000279653. Epub 2010 Apr 23. Review.

7.

The heterozygous R1441C mutation of leucine-rich repeat kinase 2 gene in a Chinese patient with Parkinson disease: A five-year follow-up and literatures review.

Peng F, Sun YM, Chen C, Luo SS, Li DK, Wang YX, Yang K, Liu FT, Zuo CT, Ding ZT, An Y, Wu JJ, Wang J.

J Neurol Sci. 2017 Feb 15;373:23-26. doi: 10.1016/j.jns.2016.12.009. Epub 2016 Dec 9. Review.

PMID:
28131193
8.

LRRK2 in Parkinson's disease: genetic and clinical studies from patients.

Kumari U, Tan EK.

FEBS J. 2009 Nov;276(22):6455-63. doi: 10.1111/j.1742-4658.2009.07344.x. Epub 2009 Oct 5. Review.

9.

Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.

Gandhi PN, Chen SG, Wilson-Delfosse AL.

J Neurosci Res. 2009 May 1;87(6):1283-95. doi: 10.1002/jnr.21949. Review.

10.

TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT.

Ling H, Kara E, Bandopadhyay R, Hardy J, Holton J, Xiromerisiou G, Lees A, Houlden H, Revesz T.

Neurobiol Aging. 2013 Dec;34(12):2889.e5-9. doi: 10.1016/j.neurobiolaging.2013.04.011. Epub 2013 May 9. Review.

11.

Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications.

Rudenko IN, Cookson MR.

Neurotherapeutics. 2014 Oct;11(4):738-50. doi: 10.1007/s13311-014-0284-z. Review.

12.

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.

Correia Guedes L, Ferreira JJ, Rosa MM, Coelho M, Bonifati V, Sampaio C.

Parkinsonism Relat Disord. 2010 May;16(4):237-42. doi: 10.1016/j.parkreldis.2009.11.004. Epub 2009 Nov 30. Review.

PMID:
19945904
13.
14.

Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease.

Bardien S, Lesage S, Brice A, Carr J.

Parkinsonism Relat Disord. 2011 Aug;17(7):501-8. doi: 10.1016/j.parkreldis.2010.11.008. Review.

PMID:
21641266
15.

Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models.

Kramer T, Lo Monte F, Göring S, Okala Amombo GM, Schmidt B.

ACS Chem Neurosci. 2012 Mar 21;3(3):151-60. doi: 10.1021/cn200117j. Epub 2012 Jan 18. Review.

16.

Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 - 2011).

Deng X, Choi HG, Buhrlage SJ, Gray NS.

Expert Opin Ther Pat. 2012 Dec;22(12):1415-26. doi: 10.1517/13543776.2012.729041. Epub 2012 Nov 6. Review.

PMID:
23126385
17.

Clinical and pathologic features of families with LRRK2-associated Parkinson's disease.

Whaley NR, Uitti RJ, Dickson DW, Farrer MJ, Wszolek ZK.

J Neural Transm Suppl. 2006;(70):221-9. Review.

PMID:
17017533
18.

Update on the genetics of Parkinson's disease.

Gasser T.

Mov Disord. 2007 Sep;22 Suppl 17:S343-50. doi: 10.1002/mds.21676. Review.

PMID:
18175395
19.

Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 - 2013).

Kethiri RR, Bakthavatchalam R.

Expert Opin Ther Pat. 2014 Jul;24(7):745-57. doi: 10.1517/13543776.2014.907275. Epub 2014 Jun 11. Review.

PMID:
24918198
20.

PARK8 LRRK2 parkinsonism.

Haugarvoll K, Wszolek ZK.

Curr Neurol Neurosci Rep. 2006 Jul;6(4):287-94. Review.

PMID:
16822348

Supplemental Content

Support Center